Sequence analysis and high-throughput immunhistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarrays [PDF]
, 2018 We aimed to immunohistochemically examine the expression of KIT (CD 117) in human posterior uveal melanoma and to analyze KIT-positive tumors for gene mutations.
Bösch, Doris +10 more
core
Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis. [PDF]
Front Syst Neurosci, 2022 Perkins M +4 more
europepmc +1 more source
Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome–positive chronic myelogenous leukemia treated with interferon‐α regimens for early chronic phase [PDF]
, 2003 Hagop M. Kantarjian +9 more
openalex +1 more source
Artificial Cells Nanomedicine and Biotechnology, 2017 Leyla Hasandoost +3 more
semanticscholar +1 more source
Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD. [PDF]
Cell Transplant, 2022 Baek DW +12 more
europepmc +1 more source
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML. [PDF]
Med Int (Lond), 2022 Yildirim MS +4 more
europepmc +1 more source
Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML [PDF]
, 2003 Shaun R. McCann +3 more
openalex +1 more source
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. [PDF]
Biomedicines, 2021 Montella L +7 more
europepmc +1 more source
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment [PDF]
, 2003 Ravi Bhatia +8 more
openalex +1 more source